Ayala PharmaceuticalsADXS

13F holders, Q1 2024 (March 31)
1holders
$0.67avg. 13F price*

At the end of Q1 2024, 1 institutions reported holding Ayala Pharmaceuticals Inc. (ADXS) in their 13F filings. The largest holder was Vermillion & White Wealth Management Group, LLC ($2).

Company
Ayala Pharmaceuticals Inc.
CUSIP
007624406
Latest filing quarter
Q4 2025

History

Number of 13F holders

01 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q1 2025: 1Q1 2025Q4 2025: 1Q4 2025

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions1$2
Exits0$0

Ownership 1 holders

Vermillion & White Wealth Management Group, LLC 0.00% New 3 $2

"% of holder's portfolio" is ADXS's weight in each manager's 13F, not the share of Ayala Pharmaceuticals Inc. the manager owns.